Bayer makes $165,000 available to support rural-based charities
Bayer Canada Named one of Canada’s Most Admired™ Corporate Cultures
Bayer Crop Science Launches 2022 Opportunity Scholarship Program for Students
Bayer extends clinical development program for finerenone with Phase II study investigating the initial combination therapy with empagliflozin in patients with chronic kidney disease and type 2 diabetes
We research, develop and market innovative products that improve the health of people and plants. Our business comprises three core divisions and one business unit. Learn more about it here.